Jodi Devlin - May 19, 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Chief of Clinical Operations
Signature
/s/ Mary Szela, Attorney-in-Fact
Stock symbol
TLSI
Transactions as of
May 19, 2025
Transactions value $
$100,321
Form type
4
Date filed
5/21/2025, 05:31 PM
Previous filing
Feb 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Devlin Jodi Chief of Clinical Operations 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela, Attorney-in-Fact 2025-05-21 0001992151

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The granted RSUs vest immediately.
F2 The sale of the shares was to cover the tax liability associated with the granted RSUs.